|
US2004229282A1
|
|
Antibodies for inhibiting blood coagulation and methods of use thereof
|
|
US2003190705A1
|
|
Method of humanizing immune system molecules
|
|
WO02059263A2
|
|
Transgenic animals comprising a humanized immune system
|
|
US2003109680A1
|
|
Antibodies for inhibiting blood coagulation and methods of use thereof
|
|
CN1464790A
|
|
T cell receptor fusions and conjugates and methods of use thereof
|
|
CN1430728A
|
|
Modulation of T-cell receptor interactions
|
|
CA2387857A1
|
|
Tissue factor antagonists and methods of use thereof
|
|
WO0018398A1
|
|
Pharmaceutically active compounds and methods of use thereof
|
|
AU2090299A
|
|
Humanized monoclonal antibodies that protect against shiga toxin induced disease
|
|
US6156514A
|
|
Methods for making recombinant cells
|
|
WO9918129A1
|
|
Soluble single-chain t-cell receptor proteins
|
|
WO9839482A1
|
|
Fusion proteins comprising bacteriophage coat protein and a single-chain t cell receptor
|
|
US6232445B1
|
|
Soluble MHC complexes and methods of use thereof
|
|
US5986065A
|
|
Antibodies for inhibiting blood coagulation and methods of use thereof
|
|
US5869270A
|
|
Single chain MHC complexes and uses thereof
|
